These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 36084707)
1. The amino acid transporter SLC7A11-mediated crosstalk implicated in cancer therapy and the tumor microenvironment. He J; Wang X; Chen K; Zhang M; Wang J Biochem Pharmacol; 2022 Nov; 205():115241. PubMed ID: 36084707 [TBL] [Abstract][Full Text] [Related]
2. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Koppula P; Zhuang L; Gan B Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412 [TBL] [Abstract][Full Text] [Related]
3. Stress-induced inhibition of nonsense-mediated RNA decay regulates intracellular cystine transport and intracellular glutathione through regulation of the cystine/glutamate exchanger SLC7A11. Martin L; Gardner LB Oncogene; 2015 Aug; 34(32):4211-8. PubMed ID: 25399695 [TBL] [Abstract][Full Text] [Related]
4. AMPKα1-mediated ZDHHC8 phosphorylation promotes the palmitoylation of SLC7A11 to facilitate ferroptosis resistance in glioblastoma. Wang Z; Wang Y; Shen N; Liu Y; Xu X; Zhu R; Jiang H; Wu X; Wei Y; Tang J Cancer Lett; 2024 Mar; 584():216619. PubMed ID: 38211651 [TBL] [Abstract][Full Text] [Related]
6. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma. Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946 [TBL] [Abstract][Full Text] [Related]
7. SHP-1/STAT3-Signaling-Axis-Regulated Coupling between BECN1 and SLC7A11 Contributes to Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma. Huang CY; Chen LJ; Chen G; Chao TI; Wang CY Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232407 [TBL] [Abstract][Full Text] [Related]
8. The CRL3 Zhou Q; Yu H; Chen Y; Ren J; Lu Y; Sun Y Proc Natl Acad Sci U S A; 2024 Jul; 121(28):e2320655121. PubMed ID: 38959043 [TBL] [Abstract][Full Text] [Related]
9. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate. Koppula P; Zhang Y; Shi J; Li W; Gan B J Biol Chem; 2017 Aug; 292(34):14240-14249. PubMed ID: 28630042 [TBL] [Abstract][Full Text] [Related]
10. SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells. Yan Y; Teng H; Hang Q; Kondiparthi L; Lei G; Horbath A; Liu X; Mao C; Wu S; Zhuang L; James You M; Poyurovsky MV; Ma L; Olszewski K; Gan B Nat Commun; 2023 Jun; 14(1):3673. PubMed ID: 37339981 [TBL] [Abstract][Full Text] [Related]
11. Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Huang Y; Dai Z; Barbacioru C; Sadée W Cancer Res; 2005 Aug; 65(16):7446-54. PubMed ID: 16103098 [TBL] [Abstract][Full Text] [Related]
12. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma. Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976 [TBL] [Abstract][Full Text] [Related]
13. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Koppula P; Zhang Y; Zhuang L; Gan B Cancer Commun (Lond); 2018 Apr; 38(1):12. PubMed ID: 29764521 [TBL] [Abstract][Full Text] [Related]
14. Cystine-glutamate antiporter xCT as a therapeutic target for cancer. Liu L; Liu R; Liu Y; Li G; Chen Q; Liu X; Ma S Cell Biochem Funct; 2021 Mar; 39(2):174-179. PubMed ID: 32749001 [TBL] [Abstract][Full Text] [Related]
15. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. Liu X; Olszewski K; Zhang Y; Lim EW; Shi J; Zhang X; Zhang J; Lee H; Koppula P; Lei G; Zhuang L; You MJ; Fang B; Li W; Metallo CM; Poyurovsky MV; Gan B Nat Cell Biol; 2020 Apr; 22(4):476-486. PubMed ID: 32231310 [TBL] [Abstract][Full Text] [Related]
16. Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11. Wang X; Chen Y; Wang X; Tian H; Wang Y; Jin J; Shan Z; Liu Y; Cai Z; Tong X; Luan Y; Tan X; Luan B; Ge X; Ji H; Jiang X; Wang P Cancer Res; 2021 Oct; 81(20):5217-5229. PubMed ID: 34385181 [TBL] [Abstract][Full Text] [Related]
17. Ferroptosis and Neurodegenerative Diseases: Insights into the Regulatory Roles of SLC7A11. Wang C; Liu H; Xu S; Deng Y; Xu B; Yang T; Liu W Cell Mol Neurobiol; 2023 Aug; 43(6):2627-2642. PubMed ID: 36988772 [TBL] [Abstract][Full Text] [Related]
18. Regulation of H2A ubiquitination and SLC7A11 expression by BAP1 and PRC1. Zhang Y; Koppula P; Gan B Cell Cycle; 2019 Apr; 18(8):773-783. PubMed ID: 30907299 [TBL] [Abstract][Full Text] [Related]
19. The DUBA-SLC7A11-c-Myc axis is critical for stemness and ferroptosis. Wang Z; Ouyang L; Liu N; Li T; Yan B; Mao C; Xiao D; Gan B; Liu S; Tao Y Oncogene; 2023 Sep; 42(36):2688-2700. PubMed ID: 37537342 [TBL] [Abstract][Full Text] [Related]
20. Suppression of the SLC7A11/glutathione axis causes ferroptosis and apoptosis and alters the mitogen-activated protein kinase pathway in nasopharyngeal carcinoma. Wang HH; Fan SQ; Zhan YT; Peng SP; Wang WY Int J Biol Macromol; 2024 Jan; 254(Pt 3):127976. PubMed ID: 37951442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]